Boundless Bio (NasdaqGS:BOLD) Earnings Call Presentation

Unlocking a New Paradigm in Cancer Treatment via ecDNA-Directed Therapies (ecDTx) Corporate Presentation March 2026 Nasdaq: BOLD @BoundlessBio Disclaimer: Forward-Looking Statements and Market Data We caution you that this presentation contains forward-looking statements about us and our industry. All statements other than statements of historical facts contained in this presentation are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors t ...